Cryo-Cell International I... (CCEL)
NYSE American: CCEL
· Real-Time Price · USD
3.88
+0.37 (10.54%)
At close: Aug 12, 2026, 3:59 PM
3.76
-3.09%
After-hours: 5:37 PM
Cryo-Cell International Inc. (CCEL) Stock Price, Analysis & Data
10.54% (1D)
| Bid | 3.81 |
| Market Cap | 31.28M |
| Revenue (ttm) | 31.13M |
| Net Income (ttm) | -2.47M |
| Beta | 0.52 |
| EPS (ttm) | -0.31 |
| PE Ratio (ttm) | n/a |
| Forward PE | 194 |
| P/B (ttm) | -1.76 |
| P/S (ttm) | 1.00 |
| Earnings Date | n/a |
| Ask | 3.87 |
| Volume | 681,377 |
| Avg. Volume (20D) | 9,437 |
| Open | 3.15 |
| Previous Close | 3.51 |
| Day's Range | 3.13 - 4.19 |
| 52-Week Range | 2.72 - 5.01 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | $0.6 (17.19%) |
| Ex-Dividend Date | May 21, 2025 |
About CCEL
Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing of PrepaCyte CB processing sy...
Industry Medical Care Facilities
Sector Healthcare
IPO Date Apr 4, 1994
Employees 72
Stock Exchange NYSE American
Ticker Symbol CCEL
Website https://www.cryo-cell.com
Financial Performance
In 2025, Cryo-Cell International's revenue was 31.57M, a decrease of -1.31% compared to the previous year's 31.99M. Earnings were -2.43M, a decrease of -704.18%.
Financial StatementsEarnings Surprise
Cryo-Cell International has released their quarterly earnings on Jul 15, 2026: